6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neurobehavioral Therapy for Substance Use Disorders
Neurobehavioral therapy is a holistic approach to treating substance use disorders that combines cognitive-behavioral techniques with an understanding of how the brain’s structure and function influence behavior. This therapy focuses on rewiring the brain's responses to triggers, cravings, and stress by helping individuals modify their behavioral patterns. Techniques used in neurobehavioral therapy include neurofeedback, cognitive restructuring, and mindfulness-based practices. This approach targets the brain’s neural pathways that reinforce addictive behaviors, helping individuals develop more adaptive responses and greater self-control. By improving both cognitive and emotional regulation, neurobehavioral therapy plays a crucial role in fostering long-term sobriety and mental well-being.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States